B
신신제약
002800KOSDAQ의약품 제조업61.5 / 100
Reference Date: 2026-07-24
Financial Score32.0 / 40
News Sentiment12.5 / 25
Momentum7.0 / 20
Disclosure10.0 / 15
AI Analysis: the debt ratio is very low with excellent financial health and ROE significantly exceeds the industry average is also solid. Slightly up 2.4% over the past month, with no recent news.
Company InformationBased on 2025 Annual Report
Business Overview
Shinshin Pharmaceutical specializes in manufacturing and selling OTC medications, particularly topical products for muscle and joint pain. The company primarily sells to pharmacies and wholesale distributors, maintaining direct sales with over 12,000 pharmacies nationwide and actively expanding exports, especially to Southeast Asia.
Number of Employees
369people
Average Salary
59.9M KRW
Score Calculation Basis
Detailed Financial Score
PER
7.11Industry Average 11.236.5Point
Lower than industry avg (good)
PBR
0.89Industry Average 0.812.5Point
Higher than industry avg (caution)
ROE
13.25Industry Average 4.017.0Point
3.3x industry avg (excellent)
Debt Ratio
3.51Industry Average 12.438.0Point
Half of industry avg (excellent)
Trend 2023~20258.0 / 10 points
Revenue Growth Rate
2.0 / 3
Avg ▲5.3% (2-year basis)
Operating Profit Growth Rate
3.0 / 3
Avg ▲35.7% (2-year basis)
ROE Trend
3.0 / 4
Avg ROE 9.5% (improving, 3yr)
Detailed News Sentiment
0 totalPositive 0Neutral 0Negative 0
Detailed Momentum
52-week position1.0Point
Near 52w low (10%, downtrend)
Current 4,360Won52-week high 6,63052-week low 4,100
1-month return4.0Point
1m +2.35% (slight rise)
Volume trend2.0Point
Volume decreasing
Detailed Disclosure
1 totalPositive 0Neutral 1Negative 0
- Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-07-01